适合活检的乳腺病变的超声检测与恶性预测:使用列线图、大语言模型和放射科医生评估的多中心临床场景研究
这项多中心多国研究纳入伊朗和土耳其三个中心的1747例乳腺病变女性,构建结合BI-RADS特征与定量形态学特征的超声列线图,并与三位放射科医生和两个ChatGPT模型比较活检推荐和恶性预测性能。融合列线图在活检推荐和恶性预测中AUC分别为0.901和0.853,优于BI-RADS列线图、形态学列线图、放射科医生和LLM,但融合列线图与BI-RADS版本差异无统计学意义。作者认为该融合列线图有潜力减少不必要的活检并增强乳腺影像的个性化决策。
要点
- 融合列线图活检推荐AUC 0.901、恶性预测AUC 0.853,在活检推荐和恶性预测中均优于其他模型、LLM和放射科医生。
- 融合列线图与BI-RADS列线图差异无统计学意义(活检推荐AUC 0.901 vs 0.898;恶性预测AUC 0.853 vs 0.834)。
- BI-RADS列线图活检推荐AUC 0.898、恶性预测AUC 0.834,高于形态学列线图、放射科医生和ChatGPT模型。
核心结论
- 所提出的BI-RADS-形态学融合列线图在指导活检决策和预测恶性方面优于单独列线图模型、LLM和放射科医生,作者认为其有潜力减少不必要的活检并增强乳腺影像的个性化决策。
研究设计与样本
- 多中心、多国研究,纳入伊朗和土耳其三个中心的1747例乳腺病变女性,从每个病变提取10个BI-RADS特征和26个形态学特征,构建基于BI-RADS、形态学和两者融合的三个列线图,由三位放射科医生(一位资深、两位普通)和两个ChatGPT模型(ChatGPT-o3和o4-mini-high)解读去标识化的乳腺病变图像,在所有队列中评估活检推荐和恶性预测的诊断性能。
诊断标准与关键数值
- 融合列线图活检推荐AUC为0.901,恶性预测AUC为0.853。
- BI-RADS列线图活检推荐AUC为0.898,恶性预测AUC为0.834。
- 形态学列线图活检推荐AUC为0.825,恶性预测AUC为0.708。
- 放射科医生1活检推荐AUC为0.820、恶性预测AUC为0.729;放射科医生2分别为0.605和0.719;放射科医生3分别为0.728和0.699。
- ChatGPT-o3活检推荐AUC为0.729、恶性预测AUC为0.689;o4-mini-high分别为0.713和0.695。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop and externally validate ultrasound nomograms combining BI-RADS features and quantitative morphometric characteristics, and to compare their performance with expert radiologists and large language models in biopsy recommendation and malignancy prediction for breast lesions.
METHODS: In this multi-center, multi-national study, 1747 women with breast lesions underwent ultrasound across three centers in Iran and Turkey. A total of 10 BIRADS and 26 morphological features were extracted from each lesion. Three nomograms based on BI-RADS, morphometric, and both feature sets were constructed. Three radiologists (one senior, two general) and two ChatGPTs including ChatGPT-o3 and o4-mini-high interpreted de-identified breast lesion images. Diagnostic performance for biopsy recommendation and malignancy prediction was assessed across all cohorts.
RESULTS: According to the pooled results, although the difference between the fused nomogram and the BI-RADS version was not statistically significant, the fused version consistently outperformed all models in biopsy recommendation and malignancy prediction (AUCs of 0.901 and 0.853, respectively) compared to BI-RADS nomogram (AUCs of 0.898 and 0.834), morphometric nomogram (AUCs of 0.825 and 0.708), radiologist1 (AUCs of 0.820 and 0.729), radiologist2 (AUCs of 0.605 and 0.719), radiologist3 (AUCs of 0.728 and 0.699), ChatGPT-o3 (AUCs of 0.729 and 0.689), and o4-mini-high (AUCs of 0.713 and 0.695).
CONCLUSIONS: The proposed BI-RADS-morphometric nomogram outperforms standalone nomogram models, LLMs, and radiologists in guiding biopsy decisions and predicting malignancy. The proposed novel fused nomogram has the potential to reduce unnecessary biopsies and enhance personalized decision-making in breast imaging.
引用
- Abbasian Ardakani A, Mohammadi A, Kuzan TY, et al. Ultrasound-based Detection and Malignancy Prediction of Breast Lesions Eligible for Biopsy: A Multi-center Clinical-scenario Study Using Nomograms, Large Language Models, and Radiologist Evaluation. Acad Radiol. 2026. PMID: 41896057. doi:10.1016/j.acra.2026.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。